Mr. Meikle has been engaged in the practice of patent law since 1987. He began his career in the intellectual property field in 1984 as a Patent Examiner at the U.S. Patent and Trademark Office. His current practice emphasizes client counseling in the areas of validity and infringement, as well as prosecution of patent applications before the USPTO and representation of clients against adverse parties in various post grant patent procedures including reexaminations, reissue applications, inter partes/ex parte reexaminations and interferences. Mr. Meikle has prepared and filed numerous appeal briefs and conducted oral hearings before the Patent Trial and Appeal Board, and its predecessor. He has also proceeded to appeal before the Court of Appeals for the Federal Circuit. Mr. Meikle has managed worldwide patent portfolios and has helped in handling oppositions, as well as patent prosecution, before the Japanese Patent Office, European Patent Office and other countries around the world. The technical fields that Mr. Meikle specializes in include organic chemistry, polymers, biochemistry and pharmaceuticals.

Mr. Meikle has managed the firm’s patent seminars since 1995 and now manages the Summer Patent Seminar. He has prepared and presented numerous lectures before international audiences regarding U.S. patent statutory law and case law developments both domestically and abroad.

Speaking Engagements

    Current Speaking Engagements

  • Nov
    03

    20th FICPI Virtual Open Forum

    20th FICPI Virtual Open Forum

    Virtual
    Learn More

Articles

  • May 23, 2014

    IP Update, Vol. 12, No. 3

    by Marc S. Weiner, Eugene T. Perez, Andrew Meikle, and Leonard Svensson | BSKB

    On March 4, 2014, the USPTO issued its Guidance (guidelines) on subject matter eligibility under 35 U.S.C. § 101 in view of the recent Supreme Court decisions of Association for Molecular Pathology v.Myriad Genetics, Inc. (2013) and MayoCollaborative Services v. Prometheus Laboratories, Inc. (2012).